Medscape19h
Leqembi Okayed for Subset of Early Alzheimer’s Patients
The European Medicines Agency re-examined clinical data of a subset of patients with one or no copies of the APOE4 gene ...
Pharmabiz5h
EMA committee recommends approval of Eisai & Biogen’s lecanemab to treat early Alzheimer’s disease
EMA committee recommends approval of Eisai & Biogen’s lecanemab to treat early Alzheimer’s disease: Tokyo Saturday, November 16, 2024, 13:00 Hrs [IST] Eisai Co., Ltd. and Biog ...
Worldcrunch on MSN19h
Lecanemab: Why This Could Be The Beginning Of The End Of Alzheimer’s
The first drug targeting the root cause of Alzheimer’s disease has been approved by the European Medicines Agency. Despite ...
CBS 58 News10h
Former governor, HHS secretary Thompson on RFK Jr. appointment: 'Give him a chance'
Nearly 20 years after he stopped serving at the nation's top health official, Tommy Thompson on Friday said he supports President-elect Donald Trump's appointment of Robert F. Ke ...